These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway. Nuwormegbe SA; Sohn JH; Kim SW Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722 [TBL] [Abstract][Full Text] [Related]
5. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells. Lee YJ; Han HJ Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942 [TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Caraci F; Gili E; Calafiore M; Failla M; La Rosa C; Crimi N; Sortino MA; Nicoletti F; Copani A; Vancheri C Pharmacol Res; 2008 Apr; 57(4):274-82. PubMed ID: 18346908 [TBL] [Abstract][Full Text] [Related]
7. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts]. Wang WM; Liu F; Chen N Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946 [TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-Δ-12, 14-prostaglandin J2 acts cooperatively with prednisolone to reduce TGF-β-induced pro-fibrotic pathways in human osteoarthritis fibroblasts. Vaamonde-Garcia C; Malaise O; Charlier E; Deroyer C; Neuville S; Gillet P; Kurth W; Meijide-Failde R; Malaise MG; de Seny D Biochem Pharmacol; 2019 Jul; 165():66-78. PubMed ID: 30936016 [TBL] [Abstract][Full Text] [Related]
9. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. Liu J; Farmer SR J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Wang W; Liu F; Chen N Mediators Inflamm; 2007; 2007():62641. PubMed ID: 18274641 [TBL] [Abstract][Full Text] [Related]
12. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts. Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228 [TBL] [Abstract][Full Text] [Related]
13. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism. Zhou B; Buckley ST; Patel V; Liu Y; Luo J; Krishnaveni MS; Ivan M; DeMaio L; Kim KJ; Ehrhardt C; Crandall ED; Borok Z PLoS One; 2012; 7(6):e38827. PubMed ID: 22745681 [TBL] [Abstract][Full Text] [Related]
14. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells. Qian J; Niu M; Zhai X; Zhou Q; Zhou Y Pharmacol Res; 2012 Sep; 66(3):219-25. PubMed ID: 22706027 [TBL] [Abstract][Full Text] [Related]
15. Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways. Deng X; Jin K; Li Y; Gu W; Liu M; Zhou L Cell Physiol Biochem; 2015; 36(3):937-46. PubMed ID: 26088859 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014 [TBL] [Abstract][Full Text] [Related]
18. Antifibrotic role of PGC-1α-siRNA against TGF-β1-induced renal interstitial fibrosis. Wang JL; Chen CW; Tsai MR; Liu SF; Hung TJ; Yu-Ju-Hung ; Chang WT; Shi MD; Hsieh PF; Yang YL Exp Cell Res; 2018 Sep; 370(1):160-167. PubMed ID: 29913155 [TBL] [Abstract][Full Text] [Related]
19. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro. Pan R; Zhang Y; Zang B; Tan L; Jin M J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091 [TBL] [Abstract][Full Text] [Related]
20. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]